• Werewolf Therapeutics' (HOWL) Buy Rating Reaffirmed at HC Wainwright

    Source: Buzz FX / 19 Nov 2024 08:36:09   America/New_York


    Werewolf Therapeutics' (HOWL) Buy Rating Reaffirmed at HC Wainwright Written by MarketBeat November 19, 2024 Share Link copied to clipboard. Werewolf Therapeutics ( NASDAQ:HOWL - Get Free Report ) 's stock had its "buy" rating reissued by H
    Read more...
Share on,